Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis

Podobne zapisy

• Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis
  od: Vic, P, i wsp.
  Wydane: (1998)
• Pharmacokinetics of Tobramycin in Adults with Cystic Fibrosis: Implications for Once-Daily Administration
  od: Beringer, P. M., i wsp.
  Wydane: (2000)
• Pharmacokinetics and Pharmacodynamics of Once-Daily Administration of Intravenous Tobramycin in Adult Patients with Cystic Fibrosis Hospitalized for an Acute Pulmonary Exacerbation
  od: Butterfield, Jill M., i wsp.
  Wydane: (2013)
• Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection
  od: Mantero, Marco, i wsp.
  Wydane: (2017)
• Absence of Cochleotoxicity Measured by Standard and High-Frequency Pure Tone Audiometry in a Trial of Once- versus Three-Times-Daily Tobramycin in Cystic Fibrosis Patients
  od: Mulheran, Michael, i wsp.
  Wydane: (2006)